BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.
References
Link | Resource |
---|---|
http://bmc.com | Product |
https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html | Release Notes Vendor Advisory |
https://seclists.org/fulldisclosure/2017/Oct/52 | Mailing List Third Party Advisory |
http://remedy.com | Product |
Configurations
Information
Published : 2021-05-19 07:15
Updated : 2021-06-01 10:14
NVD link : CVE-2017-17678
Mitre link : CVE-2017-17678
JSON object : View
CWE
CWE-79
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')
Products Affected
bmc
- remedy_mid-tier